Rights and permissions
About this article
Cite this article
Isoniazid cost study applauded, US recommendations updated. Pharmacoecon. Outcomes News 463, 2 (2004). https://doi.org/10.2165/00151234-200404630-00001
Published:
Issue Date:
DOI: https://doi.org/10.2165/00151234-200404630-00001